国家医保局要求严查

Core Points - The National Healthcare Security Administration (NHSA) has issued a notice to strengthen monitoring and handling of "dual pricing" practices in designated retail pharmacies [1] - Recent reports indicate that some pharmacies are charging higher prices for the same medications to insured patients compared to uninsured patients, which constitutes price fraud and violates service agreements [1] - The notice emphasizes the need for local healthcare departments to take responsibility, collaborate with market regulation authorities, and conduct regular inspections and investigations [1] Group 1 - The NHSA's notice addresses the issue of "dual pricing" in retail pharmacies, which involves discriminatory pricing against insured patients [1] - Legal frameworks such as the Price Law and Drug Administration Law are cited to support the crackdown on these practices [1] - The notice outlines potential penalties for pharmacies found in violation, including suspension of insurance settlements and revocation of service agreements [1]